BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

M. MOJAAT; M. Ben salem; I. Chemli; M. Hamouda; I. Handous; M. Ben salah; A. Letaief; S. Aloui; H. Skhiri

首页> 外文期刊>Kidney International Reports >BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

【24h】

BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

机译：肾移植受者之间的边缘抑制：治疗站在哪里

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction:Borderline rejection is a frequently encountered diagnosis in the post-transplant period.

机译：简介：边缘抑制是在移植后期常见的诊断。

著录项

来源
《Kidney International Reports》 |2021年第4期|共2页
作者
M. MOJAAT; M. Ben salem; I. Chemli; M. Hamouda; I. Handous; M. Ben salah; A. Letaief; S. Aloui; H. Skhiri;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. TREATMENT OF POST-TRANSPLANT DENOVO HLA DONOR SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENT IN THE ABSENCE OF REJECTION [J] . Mujtaba Muhammad A., Gamilla-Crudo Ann, Aleter Omer, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：肾移植受体中移植后Denovo HLA供体特异性抗体的治疗在没有排斥的情况下
2. TREATMENT OF POST-TRANSPLANT DENOVO HLA DONOR SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENT IN THE ABSENCE OF REJECTION [J] . Mujtaba Muhammad A., Gamilla-Crudo Ann, Aleter Omer, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：肾移植受体中移植后Denovo HLA供体特异性抗体的治疗在没有排斥的情况下
3. Outcomes of borderline T-cell rejection among kidney transplant patients at National Kidney & Transplant Institute [J] . M.A. GARIBAY, A.R. Villanueva T, I.D.A. How-Tan L Kidney International Reports . 2021,第4期

机译：肾脏移植患者在国家肾脏＆amp的临界T细胞抑制的结果; amp; 移植研究所
4. TREATMENT OF REFRACTORY ANTIBODY MEDIATED REJECTION WITH BORTEZOMIB IN TWO TRANSPLANT RECIPIENTS: THE IMPACT ON DONOR-SPECIFIC ANTI-HLA ANTIBODIES [C] . John Lunz, Judy Howe, Lawrence Jelinek, Clinical Histocompatibility Workshop. . 2010

机译：治疗难治性抗体在两个移植受者中用硼替佐米介导的抑制剂：对供体特异性抗HLA抗体的影响
5. Circulating B Cells with Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection [D] . Fischman, Clara. 2019

机译：在发育抗体介导的排斥之前，在儿科肾移植受者中可检测到具有记忆和抗体分泌表型的循环B细胞
6. Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients [O] . April A. Pottebaum, Karthikeyan Venkatachalam, Chang Liu, 2020

机译：托珠单抗治疗肾移植受者急性主动抗体介导的排斥反应的疗效和安全性
7. POS-699 BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND [O] . M. MOJAAT, M. Ben salem, I. Chemli, 2021

机译：POS-699肾移植受者之间的边缘抑制：治疗站在哪里

BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

摘要

著录项

相似文献

相关主题

期刊订阅